{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:11:07Z","timestamp":1776028267642,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neuropharm.2018.08.029","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:27:05Z","timestamp":1535556425000},"page":"343-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Antagonism of the D2 dopamine receptor enhances tremor but reduces voluntary muscle activation in humans"],"prefix":"10.1016","volume":"141","author":[{"given":"Jacob R.","family":"Thorstensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray G.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin J.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.08.029_bib1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0091-3057(86)90203-0","article-title":"Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission","volume":"24","author":"Ahlenius","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1097-4598(199803)21:3<318::AID-MUS5>3.0.CO;2-D","article-title":"Twitch interpolation of the elbow flexor muscles at high forces","volume":"21","author":"Allen","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib5","first-page":"1131","article-title":"Extent of motor unit activation during effort","volume":"51","author":"Belanger","year":"1981","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/mp.2016.105","article-title":"Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism","volume":"22","author":"Bello","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F","article-title":"Pathophysiology of chorea and bradykinesia in Huntington's disease","volume":"14","author":"Berardelli","year":"1999","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.08.029_bib8","article-title":"Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back","volume":"17","author":"Bergman","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0028-3908(73)90124-X","article-title":"Effect of amphetamine on the swimming endurance of rats","volume":"12","author":"Bhagat","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1152\/jappl.1988.64.2.884","article-title":"Effect of cocaine on exercise endurance and glycogen use in rats","volume":"64","author":"Bracken","year":"1988","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1471-4159.2007.04533.x","article-title":"Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in Guinea pig brain and SH-SY5Y human neuroblastoma cells","volume":"102","author":"Cobos","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0306-4530(86)90049-1","article-title":"Central and peripheral effects of 6-hydroxydopamine on exercise performance in rats","volume":"11","author":"Derevenco","year":"1986","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1152\/jn.1976.39.2.370","article-title":"Motor-unit activity responsible for 8- to 12-Hz component of human physiological finger tremor","volume":"39","author":"Elble","year":"1976","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12017-008-8032-3","article-title":"Neuroplasticity of dopamine circuits after exercise: implications for central fatigue","volume":"10","author":"Foley","year":"2008","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02244866","article-title":"Unlike haloperidol, clozapine slows and dampens rats' forelimb force oscillations and decreases force output in a press-while-licking behavioral task","volume":"116","author":"Fowler","year":"1994","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1037\/0735-7044.104.3.449","article-title":"A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat","volume":"104","author":"Fowler","year":"1990","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib20","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1046\/j.1471-4159.1998.70052120.x","article-title":"Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions","volume":"70","author":"Gallagher","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1152\/physrev.2001.81.4.1725","article-title":"Spinal and supraspinal factors in human muscle fatigue","volume":"81","author":"Gandevia","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0028-3908(78)90083-7","article-title":"Effects of (+)-amphetamine on the treadmill endurance performance of rats","volume":"17","author":"Gerald","year":"1978","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.179.4075.816","article-title":"Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent","volume":"179","author":"Goldstein","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1745-7254.2007.00581.x","article-title":"Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine","volume":"28","author":"Gu","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269881111424929","article-title":"Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons","volume":"26","author":"Haddad","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib28","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.neuroscience.2008.11.040","article-title":"Modulation of AMPA currents by D(1)-like but not D(2)-like receptors in spinal motoneurons","volume":"158","author":"Han","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib29","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cphy.c100087","article-title":"Motor unit","volume":"2","author":"Heckman","year":"2012","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0024-3205(85)90172-9","article-title":"Central dopaminergic activity influences rats ability to exercise","volume":"36","author":"Heyes","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0773.1987.tb01525.x","article-title":"Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol","volume":"60","author":"Hillegaart","year":"1987","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0091-3057(87)90490-4","article-title":"Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response","volume":"27","author":"Hillegaart","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0006-8993(01)03113-4","article-title":"Methamphetamine produces subsequent reductions in running time to exhaustion in mice","volume":"921","author":"Kalinski","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00221-014-4098-3","article-title":"Removing visual feedback for a single limb alters between-limb force tremor relationships during isometric bilateral contractions","volume":"233","author":"Kenway","year":"2015","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib36","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1249\/MSS.0b013e318265f356","article-title":"Effects of noradrenaline and dopamine on supraspinal fatigue in well-trained men","volume":"44","author":"Klass","year":"2012","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(96)00862-X","article-title":"Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum","volume":"319","author":"Kohno","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-2007-972683","article-title":"Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A\/2C) antagonist","volume":"18","author":"Meeusen","year":"1997","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/00007256-200636100-00006","article-title":"Central fatigue: the serotonin hypothesis and beyond","volume":"36","author":"Meeusen","year":"2006","journal-title":"Sports Med."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1113\/jphysiol.1954.sp005070","article-title":"Voluntary strength and fatigue","volume":"123","author":"Merton","year":"1954","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2006.04.048","article-title":"Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat","volume":"540","author":"Naiker","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF02244811","article-title":"Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol","volume":"106","author":"Nordstrom","year":"1992","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtherbio.2016.06.003","article-title":"Acute effects of a dopamine\/norepinephrine reuptake inhibitor on neuromuscular performance following self-paced exercise in cool and hot environments","volume":"60","author":"Onus","year":"2016","journal-title":"J. Therm. Biol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2005.03.012","article-title":"Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets","volume":"81","author":"Osinski","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bjsm.2002.000760","article-title":"Hormonal responses during prolonged exercise are influenced by a selective DA\/NA reuptake inhibitor","volume":"38","author":"Piacentini","year":"2004","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1249\/MSS.0b013e3181659c4d","article-title":"The effects of acute dopamine reuptake inhibition on performance","volume":"40","author":"Roelands","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib49","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1152\/jn.00230.2011","article-title":"Dopamine triggers skeletal muscle tone by activating D1-like receptors on somatic motoneurons","volume":"106","author":"Schwarz","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophrenia Relat. Psychoses"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib51","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1152\/jn.2000.84.4.1708","article-title":"Intermittency in the control of continuous force production","volume":"84","author":"Slifkin","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0028-3908(83)90264-2","article-title":"Effects of methylphenidate on rat endurance performance and neuromuscular transmission in vitro","volume":"22","author":"Snider","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.029_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjsm.2008.055889","article-title":"Exercising with reserve: evidence that the central nervous system regulates prolonged exercise performance","volume":"43","author":"Swart","year":"2009","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib55","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1249\/MSS.0000000000000923","article-title":"Neural contributions to muscle fatigue: from the brain to the muscle and back again","volume":"48","author":"Taylor","year":"2016","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1249\/mss.0b013e31802d3ad3","article-title":"Aging, visuomotor correction, and force fluctuations in large muscles","volume":"39","author":"Tracy","year":"2007","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib57","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.lfs.2007.01.038","article-title":"Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine","volume":"80","author":"Uchida","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00221-002-1081-1","article-title":"Temporal capacity of short-term visuomotor memory in continuous force production","volume":"145","author":"Vaillancourt","year":"2002","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib59","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1113\/jphysiol.2004.079202","article-title":"Acute dopamine\/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions","volume":"565","author":"Watson","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib60","first-page":"417","article-title":"Effect of varient dosages of amphetamine upon endurance","volume":"44","author":"Williams","year":"1973","journal-title":"Restor. Q."},{"key":"10.1016\/j.neuropharm.2018.08.029_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuroscience.2007.07.052","article-title":"Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study","volume":"149","author":"Zhu","year":"2007","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T16:30:18Z","timestamp":1661877018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818305707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":61,"alternative-id":["S0028390818305707"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of the D2 dopamine receptor enhances tremor but reduces voluntary muscle activation in humans","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}